Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07508605
What this trial is testing

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital 20
Large-scale testing (Phase 3)Study completedNCT01987505
What this trial is testing

MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for Lymphoma

Who this might be right for
Lymphoma, Non Hodgkin
Hoffmann-La Roche 140
Post-approval studies (Phase 4)Study completedNCT00168727
What this trial is testing

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Low-Grade
Biogen 12
Early research (Phase 1)Enrolling By InvitationNCT06375993
What this trial is testing

Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Who this might be right for
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)+4 more
Adicet Therapeutics 180
Early research (Phase 1)Not Yet RecruitingNCT06318884
What this trial is testing

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd. 76
Testing effectiveness (Phase 2)UnknownNCT01279707
What this trial is testing

Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)

Who this might be right for
Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia
Queen Mary University of London 55
Very early researchLooking for participantsNCT06693973
What this trial is testing

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Testing effectiveness (Phase 2)Looking for participantsNCT06985472
What this trial is testing

Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL

Who this might be right for
Initial MZLUntreated MZLBTKi+1 more
Li Zhiming 33
Not applicableUnknownNCT00400907
What this trial is testing

Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in AdultsLymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 667
Large-scale testing (Phase 3)UnknownNCT01933711
What this trial is testing

Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma

Who this might be right for
CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
University Hospital Heidelberg 328
Testing effectiveness (Phase 2)Study completedNCT02738775
What this trial is testing

Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
TG Therapeutics, Inc. 49
Early research (Phase 1)Study completedNCT03218072
What this trial is testing

Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas

Who this might be right for
B-cell Lymphomas
Shanghai Henlius Biotech 12
Post-approval studies (Phase 4)Study completedNCT00476164
What this trial is testing

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Who this might be right for
Kidney TransplantationGraft RejectionImmunosuppression
King's College London 62
Testing effectiveness (Phase 2)Study completedNCT00494780
What this trial is testing

Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 59
Large-scale testing (Phase 3)Active Not RecruitingNCT06284122
What this trial is testing

Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 790
Testing effectiveness (Phase 2)WithdrawnNCT00003605
What this trial is testing

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)UnknownNCT03398967
What this trial is testing

A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Chinese PLA General Hospital 80
Testing effectiveness (Phase 2)UnknownNCT00293475
What this trial is testing

Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Central Nervous System Lymphoma
OHSU Knight Cancer Institute 81
Testing effectiveness (Phase 2)Looking for participantsNCT05826535
What this trial is testing

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Who this might be right for
Relapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Lyell Immunopharma, Inc. 270
Testing effectiveness (Phase 2)WithdrawnNCT00093314
What this trial is testing

HuMax-CD20 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
GlaxoSmithKline
Next Page